Perspective Therapeutics, Inc. — Director's Dealing 2023

Dec 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Perspective Therapeutics, Inc. (CATX)
CIK: 0000728387
Period of Report: 2023-12-12

Reporting Person: Spoor Johan M. (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-12-12	Stock Options (right to buy)	$0.24	A	3338878	Acquired	2033-12-12	Common Stock (3338878)	Direct

Footnotes

F1: 25% vested as of 12/12/2023, and the remaining 75% will vest over the next three (3) years, commencing on 12/12/2024, until fully vested.